HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.

AbstractBACKGROUND:
Atrial fibrillation is common in patients with heart failure, but outcomes of patients with both conditions who receive cardiac resynchronization therapy with defibrillator (CRT-D) compared with an implantable cardioverter-defibrillator (ICD) alone are unclear.
METHODS AND RESULTS:
Using the National Cardiovascular Data Registry's ICD Registry linked with Medicare claims, we identified 8951 patients with atrial fibrillation who were eligible for CRT-D and underwent first-time device implantation for primary prevention between April 2006 and December 2009. We used Cox proportional hazards models and inverse probability-weighted estimates to compare outcomes with CRT-D versus ICD alone. Cumulative incidence of mortality (744 [33%] for ICD; 1893 [32%] for CRT-D) and readmission (1788 [76%] for ICD; 4611 [76%] for CRT-D) within 3 years and complications within 90 days were similar between groups. After inverse weighting for the probability of receiving CRT-D, risks of mortality (hazard ratio, 0.83; 95% confidence interval, 0.75-0.92), all-cause readmission (hazard ratio, 0.86; 95% confidence interval, 0.80-0.92), and heart failure readmission (hazard ratio, 0.68; 95% confidence interval, 0.62-0.76) were lower with CRT-D compared with ICD alone. There was no significant difference in the 90-day complication rate (hazard ratio, 0.88; 95% confidence interval, 0.60-1.29). We observed hospital-level variation in the use of CRT-D among patients with atrial fibrillation.
CONCLUSIONS:
Among eligible patients with heart failure and atrial fibrillation, CRT-D was associated with lower risks of mortality, all-cause readmission, and heart failure readmission, as well as with a similar risk of complications compared with ICD alone.
AuthorsPrateeti Khazanie, Melissa A Greiner, Sana M Al-Khatib, Jonathan P Piccini, Mintu P Turakhia, Paul D Varosy, Frederick A Masoudi, Lesley H Curtis, Adrian F Hernandez, National Cardiovascular Data Registry
JournalCirculation. Heart failure (Circ Heart Fail) Vol. 9 Issue 6 (06 2016) ISSN: 1941-3297 [Electronic] United States
PMID27296396 (Publication Type: Comparative Study, Journal Article, Observational Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Copyright© 2016 American Heart Association, Inc.
Topics
  • Aged
  • Aged, 80 and over
  • Atrial Fibrillation (diagnosis, mortality, physiopathology, therapy)
  • Cardiac Resynchronization Therapy (adverse effects, mortality)
  • Cardiac Resynchronization Therapy Devices
  • Chi-Square Distribution
  • Comparative Effectiveness Research
  • Death, Sudden, Cardiac (etiology, prevention & control)
  • Defibrillators, Implantable
  • Electric Countershock (adverse effects, instrumentation, mortality)
  • Female
  • Heart Failure (diagnosis, mortality, physiopathology, therapy)
  • Humans
  • Kaplan-Meier Estimate
  • Logistic Models
  • Male
  • Medicare
  • Patient Readmission
  • Primary Prevention (instrumentation)
  • Propensity Score
  • Proportional Hazards Models
  • Registries
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: